Spitzer TR - Search Results

1

Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020.

Spitzer TR, Ambinder RF, Lee JY, Kaplan LD, Wachsman W, Straus DJ, Aboulafia DM, Scadden DT. Spitzer TR, et al. Biol Blood Marrow Transplant. 2008 Jan;14(1):59-66. doi: 10.1016/j.bbmt.2007.03.014. Biol Blood Marrow Transplant. 2008. PMID: 18158962 Free PMC article. Clinical Trial.

2

Deeg HJ, Spitzer TR, Cottler-Fox M, Cahill R, Pickle LW. Deeg HJ, et al. Among authors: spitzer tr. Bone Marrow Transplant. 1991 Mar;7(3):193-8. Bone Marrow Transplant. 1991. PMID: 2059756 Clinical Trial.

3

Escalating doses of etoposide with cyclophosphamide and fractionated total body irradiation or busulfan as conditioning for bone marrow transplantation.

Spitzer TR, Cottler-Fox M, Torrisi J, Cahill R, Greenspan A, Lynch M, Deeg HJ. Spitzer TR, et al. Bone Marrow Transplant. 1989 Sep;4(5):559-65. Bone Marrow Transplant. 1989. PMID: 2676044

4

Phase I-II trial of high-dose cyclophosphamide, carboplatin and autologous bone marrow or peripheral blood stem cell rescue.

Spitzer TR, Cirenza E, McAfee S, Foelber R, Zarzin J, Cahill R, Mazumder A. Spitzer TR, et al. Bone Marrow Transplant. 1995 Apr;15(4):537-42. Bone Marrow Transplant. 1995. PMID: 7655378 Clinical Trial.

5

Allogeneic peripheral blood stem cell transplantation.

Spitzer TR. Spitzer TR. J Infus Chemother. 1996 Winter;6(1):33-8. J Infus Chemother. 1996. PMID: 8748005 Review.

6

Cellular modulation of acute graft-vs.-host disease.

Colby C, Sykes M, Sachs DH, Spitzer TR. Colby C, et al. Among authors: spitzer tr. Biol Blood Marrow Transplant. 1997 Dec;3(6):287-93. Biol Blood Marrow Transplant. 1997. PMID: 9502295 Review.

7

Early vs delayed administration of G-CSF following autologous peripheral blood stem cell transplantation.

Colby C, McAfee SL, Finkelstein DM, Spitzer TR. Colby C, et al. Among authors: spitzer tr. Bone Marrow Transplant. 1998 May;21(10):1005-10. doi: 10.1038/sj.bmt.1701203. Bone Marrow Transplant. 1998. PMID: 9632273

8

Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation.

Toh HC, McAfee SL, Sackstein R, Cox BF, Colby C, Spitzer TR. Toh HC, et al. Among authors: spitzer tr. Bone Marrow Transplant. 1999 Oct;24(8):891-5. doi: 10.1038/sj.bmt.1701994. Bone Marrow Transplant. 1999. PMID: 10516702

9

A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.

Colby C, McAfee S, Sackstein R, Finkelstein D, Fishman J, Spitzer T. Colby C, et al. Bone Marrow Transplant. 1999 Oct;24(8):897-902. doi: 10.1038/sj.bmt.1702004. Bone Marrow Transplant. 1999. PMID: 10516703 Clinical Trial.

10

High-dose cyclophosphamide + carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma - a phase II study.

Toh HC, McAfee SL, Sackstein R, Multani P, Cox BF, Garcia-Carbonero R, Colby C, Spitzer TR. Toh HC, et al. Among authors: spitzer tr. Bone Marrow Transplant. 2000 Jan;25(1):19-24. doi: 10.1038/sj.bmt.1702091. Bone Marrow Transplant. 2000. PMID: 10654009 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

237 results

Search Page

Filters